Personalized immune cell therapy tested for Tough-to-Treat lymphoma
NCT ID NCT05784441
Summary
This early-stage study is testing the safety and finding the right dose of a new personalized cell therapy called JNJ-90009530 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back. The main goals are to see if the treatment is safe and to learn if it can help shrink the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Hospital
Heidelberg, 3084, Australia
-
Hadassah Medical Center
Jerusalem, 9112001, Israel
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Monash Medical Centre
Clayton, 3168, Australia
-
Royal Brisbane and Women's Hospital
Herston, 4029, Australia
-
Royal Prince Alfred Hospital
Camperdown, 2050, Australia
-
Rutgers University
New Brunswick, New Jersey, 08901, United States
-
Sheba Medical Center
Ramat Gan, 5266202, Israel
-
University College London Hospitals
London, NW1 2BU, United Kingdom
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Iowa Hospital
Iowa City, Iowa, 52242, United States
-
University of Kentucky
Lexington, Kentucky, 40506, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Westmead Hospital
Westmead, 2145, Australia
Conditions
Explore the condition pages connected to this study.